BAP1 loss defines a new class of renal cell carcinoma

被引:738
作者
Pena-LlopiS, Samuel [2 ,3 ]
Vega-Rubin-de-Celis, Silvia [1 ,2 ,3 ]
Liao, Arnold [4 ]
Leng, Nan [4 ]
Pavia-Jimenez, Andrea [1 ,2 ,3 ]
Wang, Shanshan [1 ,2 ,3 ]
Yamasaki, Toshinari [1 ,2 ,3 ]
Zhrebker, Leah [2 ,3 ]
Sivanand, Sharanya [1 ,2 ,3 ]
Spence, Patrick [1 ,3 ]
Kinch, Lisa [5 ]
Hambuch, Tina [4 ]
Jain, Suneer [4 ]
Lotan, Yair [6 ]
Margulis, Vitaly [6 ]
Sagalowsky, Arthur I. [6 ]
Summerour, Pia Banerji [3 ,7 ]
Kabbani, Wareef [8 ]
Wong, S. W. Wendy [9 ]
Grishin, Nick [5 ]
Laurent, Marc [4 ]
Xie, Xian-Jin [3 ]
Haudenschild, Christian D. [4 ]
Ross, Mark T. [9 ]
Bentley, David R. [9 ]
Kapur, Payal [8 ]
Brugarolas, James [1 ,2 ,3 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA
[3] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA
[4] Illumina Inc, San Diego, CA USA
[5] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
[6] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
[7] Univ Texas SW Med Ctr Dallas, Dept Clin Genet, Dallas, TX 75390 USA
[8] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
[9] Illumina Cambridge Ltd, Saffron Walden, England
基金
美国国家卫生研究院;
关键词
BRCA1-ASSOCIATED PROTEIN-1; OCULOCUTANEOUS ALBINISM; UBIQUITIN HYDROLASE; SOMATIC MUTATIONS; FREQUENT MUTATION; TUMOR-SUPPRESSOR; GENE-EXPRESSION; FACTOR-I; P-GENE; COMPLEX;
D O I
10.1038/ng.2323
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The molecular pathogenesis of renal cell carcinoma (RCC) is poorly understood. Whole-genome and exome sequencing followed by innovative tumorgraft analyses (to accurately determine mutant allele ratios) identified several putative two-hit tumor suppressor genes, including BAP1. The BAP1 protein, a nuclear deubiquitinase, is inactivated in 15% of clear cell RCCs. BAP1 cofractionates with and binds to HCF-1 in tumorgrafts. Mutations disrupting the HCF-1 binding motif impair BAP1-mediated suppression of cell proliferation but not deubiquitination of monoubiquitinated histone 2A lysine 119 (H2AK119ub1). BAP1 loss sensitizes RCC cells in vitro to genotoxic stress. Notably, mutations in BAP1 and PBRM1 anticorrelate in tumors (P = 3 x 10(-5)), and combined loss of BAP1 and PBRM1 in a few RCCs was associated with rhabdoid features (q = 0.0007). BAP1 and PBRM1 regulate seemingly different gene expression programs, and BAP1 loss was associated with high tumor grade (q = 0.0005). Our results establish the foundation for an integrated pathological and molecular genetic classification of RCC, paving the way for subtype-specific treatments exploiting genetic vulnerabilities.
引用
收藏
页码:751 / U174
页数:11
相关论文
共 59 条
[1]   Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers [J].
Abdel-Rahman, Mohamed H. ;
Pilarski, Robert ;
Cebulla, Colleen M. ;
Massengill, James B. ;
Christopher, Benjamin N. ;
Boru, Getachew ;
Hovland, Peter ;
Davidorf, Frederick H. .
JOURNAL OF MEDICAL GENETICS, 2011, 48 (12) :856-859
[2]   Genetics and epigenetics of renal cell cancer [J].
Baldewijns, Marcella M. L. ;
van Vlodrop, Iris J. H. ;
Schouten, Leo J. ;
Soetekouw, Patricia M. M. B. ;
de Bruine, Adriaan P. ;
van Engeland, Manon .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2008, 1785 (02) :133-155
[3]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[4]   Accurate whole human genome sequencing using reversible terminator chemistry [J].
Bentley, David R. ;
Balasubramanian, Shankar ;
Swerdlow, Harold P. ;
Smith, Geoffrey P. ;
Milton, John ;
Brown, Clive G. ;
Hall, Kevin P. ;
Evers, Dirk J. ;
Barnes, Colin L. ;
Bignell, Helen R. ;
Boutell, Jonathan M. ;
Bryant, Jason ;
Carter, Richard J. ;
Cheetham, R. Keira ;
Cox, Anthony J. ;
Ellis, Darren J. ;
Flatbush, Michael R. ;
Gormley, Niall A. ;
Humphray, Sean J. ;
Irving, Leslie J. ;
Karbelashvili, Mirian S. ;
Kirk, Scott M. ;
Li, Heng ;
Liu, Xiaohai ;
Maisinger, Klaus S. ;
Murray, Lisa J. ;
Obradovic, Bojan ;
Ost, Tobias ;
Parkinson, Michael L. ;
Pratt, Mark R. ;
Rasolonjatovo, Isabelle M. J. ;
Reed, Mark T. ;
Rigatti, Roberto ;
Rodighiero, Chiara ;
Ross, Mark T. ;
Sabot, Andrea ;
Sankar, Subramanian V. ;
Scally, Aylwyn ;
Schroth, Gary P. ;
Smith, Mark E. ;
Smith, Vincent P. ;
Spiridou, Anastassia ;
Torrance, Peta E. ;
Tzonev, Svilen S. ;
Vermaas, Eric H. ;
Walter, Klaudia ;
Wu, Xiaolin ;
Zhang, Lu ;
Alam, Mohammed D. ;
Anastasi, Carole .
NATURE, 2008, 456 (7218) :53-59
[5]   Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney [J].
Beroukhim, Rameen ;
Brunet, Jean-Philippe ;
Di Napoli, Arianna ;
Mertz, Kirsten D. ;
Seeley, Apryle ;
Pires, Maira M. ;
Linhart, David ;
Worrell, Robert A. ;
Moch, Holger ;
Rubin, Mark A. ;
Sellers, William R. ;
Meyerson, Matthew ;
Linehan, W. Marston ;
Kaelin, William G., Jr. ;
Signoretti, Sabina .
CANCER RESEARCH, 2009, 69 (11) :4674-4681
[6]   The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma [J].
Bott, Matthew ;
Brevet, Marie ;
Taylor, Barry S. ;
Shimizu, Shigeki ;
Ito, Tatsuo ;
Wang, Lu ;
Creaney, Jenette ;
Lake, Richard A. ;
Zakowski, Maureen F. ;
Reva, Boris ;
Sander, Chris ;
Delsite, Robert ;
Powell, Simon ;
Zhou, Qin ;
Shen, Ronglai ;
Olshen, Adam ;
Rusch, Valerie ;
Ladanyi, Marc .
NATURE GENETICS, 2011, 43 (07) :668-U81
[7]  
BRETHEAU D, 1995, CANCER, V76, P2543, DOI 10.1002/1097-0142(19951215)76:12<2543::AID-CNCR2820761221>3.0.CO
[8]  
2-S
[9]   Renal-cell carcinoma - Molecular pathways and therapies [J].
Brugarolas, James .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :185-187
[10]  
Brugarolas J, 2012, RENAL CELL CARCINOMA: TRANSLATIONAL BIOLOGY, PERSONALIZED MEDICINE, AND NOVEL THERAPEUTIC TARGETS, P161, DOI 10.1007/978-1-4614-2400-0_8